Injection delivery system developer ApiJect announced today that it completed a private investment round worth $111 million. Royalty Pharma and Jefferies Financial Group led the investment round. Jefferies also acquired a revenue interest in addition to equity through the financing. According to a news release, the investment round values ApiJect at approximately $300 million. Jefferies […]
ApiJect Systems
ApiJect appoints former WHO director as chief global health officer
ApiJect Systems announced today that Edward Kelley has joined as chief global health officer for the company. Kelley will take on the role at Stamford, Connecticut-based ApiJect, which provides a platform for pharmaceutical companies to fill-finish their injectable medicines in prefilled delivery systems, as well as become a leader of its related organizations, ApiLabs and […]
Fareva, ApiJect ink 10-year licensing agreement on fill-finish production lines
Fareva and ApiJect Systems today announced a licensing agreement to fill-finish more than 500 million injectable drug doses per year. Under the agreement, Fareva intends to invest more than $56.5 million to install three blow-fill-seal production lines with support from the Government of France through the France Relance industry initiative, as well as the Investments […]
Injectable medicine technology developer ApiJect Systems appoints new COO
ApiJect Systems announced that Raymond J. Guidotti joined the company as its new chief operating officer. Stamford, Conn.-based ApiJect, which develops technologies for vaccines and injectable medicines to be filled, finished and delivered, made the personnel move effective on March 1, 2021, according to a news release. Guidotti is a veteran of more than 30 […]